Hyperprolactinaemia due to hypothalamic-pituitary disease or drug-induced in patients with erectile dysfunction

Andrologia

Volumn 40, Issue 4, 2008, Pages 240-244

  Venetikou, M S ^a,b,c   Lambou, T ^a   Gizani, D ^a  

^a Athens Medical Sex Institute   (Greece)

^b UNIVERSITY OF WEST ATTICA   (Greece)

^c NONE   (Greece)

Author keywords

Erectile dysfunction; Psychogenic; Tumorous and drug induced hyperprolactinaemia; Vascular

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; NEUROLEPTIC AGENT; PROLACTIN;

ARTICLE; DRUG INDUCED DISEASE; ENDOCRINE DISEASE; ENDOCRINE FUNCTION TEST; ERECTILE DYSFUNCTION; HUMAN; HYPERPROLACTINEMIA; HYPOPHYSIS ADENOMA; HYPOPHYSIS DISEASE; HYPOPHYSIS TUMOR; HYPOTHALAMUS DISEASE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PROLACTIN BLOOD LEVEL; PROLACTINOMA; VASCULAR DISEASE;

ADENOMA; ANTIDEPRESSIVE AGENTS; ANTIHYPERTENSIVE AGENTS; ANTIPSYCHOTIC AGENTS; ERECTILE DYSFUNCTION; HUMANS; HYPERPROLACTINEMIA; HYPOTHALAMIC DISEASES; MAGNETIC RESONANCE IMAGING; MALE; PITUITARY DISEASES; PITUITARY FUNCTION TESTS; PITUITARY NEOPLASMS; PROLACTINOMA;

EID: 47749144026     PISSN: 03034569     EISSN: 14390272     Source Type: Journal    
DOI: 10.1111/j.1439-0272.2008.00850.x     Document Type: Article

References (45)

1. Accar D, Cayan S, Bozlu M, Akbay E (2004) Is routine hormonal measurement necessary in initial evaluation of men with erectile dysfunction? Arch Androl 50 : 247 253.
2. Ackerman MD, Carey MP (1995) Psychology's role in the assessment of erectile dysfunction. Historical precedents, current knowledge and methods. J Consult Clin Psychol 63 : 862 876.
3. Akkus E, Kadioglou A, Esen A, Doran S, Ergen A, Anafarta K, Hattat H (2002) Prevalence and correlates of erectile dysfunction in Turkey: a population based study. Eur Urol 4 : 298 304.
4. Akpunonu BE, Mutgi AB, Federman DJ, York J, Woldenberg LS (1994) Routine prolactin measurement is not necessary in the initial evaluation of male impotence. J Gen Intern Med 9 : 336 338.
5. Althof SE, Seftel AD (1995) The evaluation and management of erectile dysfunction. Psychiatr Clin North Am 18 : 171 192.
6. Araujo AB, Durante R, Feldman HA, Goldstein I, McKinlay JB (1998) The relationship between depressive symptoms and male erectile dysfunction, cross-sectional results from MMAS. Psychosom Med 60 : 458 465.
7. Bancroft J, Janssen E (2001) Psychogenic erectile dysfunction in the era of pharmacotherapy. In : Current Clinical Urology. Male Sexual Function. A Guide to Clinical Management. Mulcahy JJ (ed). Humana Press, Totowa, NJ, USA, pp 79 89.
8. Buvat J, Lemaire A, Buvat-Herbaut M, Fourlinnie K, Racadot A, Fossati P (1985) Hyperprolactinaemia and sexual function in men. Horm Res 22 : 196 203.
9. Buvat J, Lemaire A (1997) Endocrine screening in 1022 men with erectile dysfunction: clinical significance and cost effective strategy. J Urol 158 : 1764 1767.
10. Calle-Rodrigue RD, Giannini C, Scheithauer BW, Lloyd RV, Wollan PC, Kovacs KT, Stefaneanu L, Ebright AB, Abboud CF, Davis DH (1998) Prolactinomas in male and female patients. A comparative clinicopathologic study. Mayo Clin Proc 73 : 1046 1052.
11. Caspari D, Huerbgen EM, Derouet H (1999) Interdisciplinary assessment and follow up of patients with erectile dysfunction - psychiatric aspects. Int J Impot Res 11 : 213 217.
12. Christ GJ (1995) The penis as a vascular organ. The importance of corporal smooth-muscle tone in the control of erection. Urol Clin North Am 22 : 727 745.
13. Ciccarelli A, Guerra E, Rosa MD, Milone F, Zarrilli S, Lombardi G (2005) Prolactin secreting adenomas in male patients. Pituitary 8 : 39 42.
14. Corona G, Mannucci E, Mansani L, Petrone M, Grommi R, Manani G, Forti G, Maggi M (2004) Aging and pathogenesis of erectile dysfunction. Int J Impot Res 16 : 395 402.
15. Cummings MH, Alexander WD (1999) Erectile dysfunction in patients with diabetes. Hosp Med 60 : 638 644.
16. Delavierre D, Girard P, Peneau M, Ibrahim H (1999) Should plasma prolactin assay be routinely performed in the assessment of erectile dysfunction? Report of a series of 445 patients. Review of the literature. Prog Urol 9 : 1097 1101.
17. De Wire DM (1996) Evaluation and treatment of erectile dysfunction. Am Fam Physician 53 : 2101 2108.
18. El-Beheiry A, Souka A, El-Kamshouski A, Hussein S, El-Sabah K (1988) Hyperprolactinaemia and impotence. Arch Androl 21 : 211 214.
19. Fabbri A, Aversa A, Isidori A (1997) Erectile dysfunction: an overview. Hum Reprod Update 3 : 455 466.
20. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB (1994) Impotence and its medical and psychosocial correlates: results of the MMAS. J Urol 151 : 54 61.
21. Franks S, Jacobs HS (1983) Hyperprolactinaemia. Clin Endocrinol Metab 12 : 641 668.
22. Hartmann U (1997) Psychological subtypes of erectile dysfunction: results of statistical analyses and clinical practice. World J Urol 15 : 56 64.
23. Hellsrom WJG (2007) Current safety and tolerability issues in men with erectile dysfunction receiving PDE5 inhibitors. Int J Clin Pract 61 : 1547 1554.
24. Joannes CB, Arauyo AB, Feldman HA, Derby CA, Kleiman KP, McKinlay JB (2000) Incidence of erectile dysfunction in men 40 to 69 years old. Longitudinal results from the Massachusetts male aging study. J Urol 163 : 460 463.
25. Johri AM, Heaton JP, Morales A (2001) Severe erectile dysfunction is a marker for hyperprolactinaemia. Int J Impot Res 13 : 176 182.
26. Kaiser FE (1999) Erectile dysfunction in the aging man. Med Clin North Am 83 : 1267 1278.
27. Kim YC (2000) Algorithm for diagnosis and treatment of erectile dysfunction in the era of sildenafil citrate. Int J Androl 23 (Suppl 2 85 86.
28. Kitamura M, Oka T, Okuyama A (2002) Hyperprolactinaemia and erectile dysfunction. Nippon Rinsko (Japan) 60 : 341 343.
29. Langtry HD, Markham A (1999) Sildenafil; a review of its use in erectile dysfunction. Drugs 57 : 967 989.
30. Levy A, Crowley T, Gingall C (2000) Non-surgical management of erectile dysfunction. Clin Endocrinol 52 : 253 260.
31. Lue TF (1999) Impotence and infertility. In : Atlas of Clinical Urology, Vol. 1. Vaughan EDJ, Perlmutter AP (eds). Current Medicine, Philadelphia, PA, USA.
32. Lue TF (2000) Erectile dysfunction. N Engl J Med 342 : 1802 1813.
33. Molitch ME (2005) Medication-induced hyperprolactinaemia. Mayo Clin Proc 80 : 1050 1057.
34. Moreira ED Jr., Lbo CF, Diament A, Nicolosi A, Glasser DB (2003) Incidence of erectile dysfunction in men 40 to 69 years old: results from a population based cohort study in Brasil. Urology 61 : 431 436.
35. Nicolosi A, Moreira ED Jr., Shirai M, Bin Mohol Tambi MI, Glasser DB (2003) Epidemiology of erectile dysfunction in four countries: a cross national study of the prevalence of erectile dysfunction. Urology 61 : 201 206.
36. Oselo F, Note S, Morikawa K, Endo J, Taniguchi A, Imura H (1985) Influence of chronic hyperprolactinaemia induced by sulpiride on the hypothalamic-pituitary-testicular axis in normal men. Fertil Steril 44 : 106 111.
37. Pollice R, Di Giovambattista E, Tomassini A, Di Pucchio A, Ussorio D, Roncone R, Casacchia M (2007) Antipsychotic-induced hyperprolactinaemia; clinical consequences and therapeutic strategies. Clin Ther 158 : 173 179.
38. Sachs BD (2003) The false organic-psychogenic distinction and related problems in the classification of erectile dysfunction. Int J Impot Res 15 : 72 78.
39. Salonia A, Rigatti P, Montorsi F (2003) Sildenafil in erectile dysfunction. A critical review. Curr Med Res Opin 19 : 241 262.
40. Schwartz MF, Bauman JE, Masters WH (1982) Hyperprolactinaemia and sexual disorders in men. Bio Psychiat 17 : 861 876.
41. Spark RF, White RA, Connolly PB (1980) Impotence is not always psychogenic. Newer insights into hypothalamic-pituitary gonadal dysfunction. JAMA 243 : 750 755.
42. Speckens AE, Hengeveld MW, Lycklama a Nijeholt G, van Hemert AM, Hawton KE (1995) Psychosexual functioning of partners of men with presumed non-organic erectile dysfunction: cause or consequence of the disorder. Arch Sex Behav 24 : 157 172.
43. Spollett GR (1999) Assessment and management of erectile dysfunction in men with diabetes. Diabetes Educ 25 : 65 73.
44. Wellmer A, Shariet MK, Knowles CH, Misra VP, Kopelman P, Ralph D, Anand P (1999) Quantative sensory and autonomic testing in male diabetic patients with erectile dysfunction. BJU Int 83 : 66 70.
45. Wright PJ (2006) Comparison of phosphodiesterase type 5 (PDE5) inhibitors. Int J Clin Pract 60 : 967 975.